Author

M. J. Wurm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:virus· 1

Frequent Co-Authors

J. Kint· 2 shared P. Pino· 2 shared A. T. Shivgan· 1 shared A. V. KAJAVA· 1 shared B. Chen· 1 shared D. I. Stuart· 1 shared D. Kiseljak· 1 shared D. R. Burton· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

J. Kint

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Site-specific steric control of SARS-CoV-2 spike glycosylation

J. D. Allen, H. Chawla, F. Samsudin, L. Zuzic, A. T. Shivgan, Y. Watanabe, W.-T. He, S. Callaghan, G. Song, P. Yong, P. J. M. Brouwer, Y. Song, Y. Cai, H. M. E. Duyvesteyn, T. Malinauskas, , M. Crispin

The paper compares glycosylation patterns of recombinant SARS-CoV-2 spike proteins across labs with infectious virus S protein, finding conserved site-specific glycan maturation stalling linked to protein structure.

bioRxiv · Mar 8, 2021 · PreprintBiochemistry

Trimeric SARS-CoV-2 Spike proteins produced from CHO-cells in bioreactors are high-quality antigens

P. Pino, J. Kint, D. Kiseljak, V. Agnolon, G. Corradin, A. V. KAJAVA, P. Rovero, R. Dijkman, G. d. Hartog, J. S. McLellan, P. Byrne, M. J. Wurm, F. M. Wurm

This paper describes a scalable method to produce high-quality trimeric SARS-CoV-2 Spike proteins for vaccines and diagnostics.

bioRxiv · Nov 15, 2020Cell Biology